A deeper understanding of how these transcription factors function in T cell biology may help further define the mechanisms underlying TGF-β-driven formation of tumor tissue-resident memory cells, as well as novel targets to attenuate deleterious TGF-β signaling while maintaining beneficial effects such as the upregulation of CD103. This evidence concerns the gene TGFB1 and neoplasm.